683269-48-9 Usage
Description
(R)-benzyl piperidin-3-ylmethylcarbamate is a chemical compound belonging to the carbamate class. As the (R)-enantiomer of benzyl piperidin-3-ylmethylcarbamate, it possesses a unique spatial arrangement of atoms. (R)-benzyl piperidin-3-ylmethylcarbamate is recognized for its potential applications in the pharmaceutical and agricultural sectors due to its versatile nature.
Uses
Used in Pharmaceutical Industry:
(R)-benzyl piperidin-3-ylmethylcarbamate is used as a precursor in the synthesis of other pharmaceuticals, contributing to the development of new drugs. Its role in research and development is crucial for creating innovative medications.
Used in Medical Treatment:
(R)-benzyl piperidin-3-ylmethylcarbamate is being studied for its potential role in treating various medical conditions, such as neurological disorders and pain management. Its effectiveness in these areas could lead to improved patient outcomes and quality of life.
Used in Agricultural Industry:
(R)-benzyl piperidin-3-ylmethylcarbamate has shown promise as an insecticide and is being investigated for its potential use in pest control. Its application in this industry could help protect crops and contribute to more sustainable agricultural practices.
Check Digit Verification of cas no
The CAS Registry Mumber 683269-48-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,8,3,2,6 and 9 respectively; the second part has 2 digits, 4 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 683269-48:
(8*6)+(7*8)+(6*3)+(5*2)+(4*6)+(3*9)+(2*4)+(1*8)=199
199 % 10 = 9
So 683269-48-9 is a valid CAS Registry Number.
683269-48-9Relevant articles and documents
Design and synthesis of potent and highly selective thrombin inhibitors
Hilpert,Ackermann,Banner,Gast,Gubernator,Hadvary,Labler,Muller,Schmid,Tschopp,Van de Waterbeemd
, p. 3889 - 3901 (2007/10/02)
Thrombin, a serine protease, plays a central role in the initiation and propagation of thrombotic events. An extensive search for new thrombin inhibitors was performed, using an unconventional approach. Screening of small basic molecules for binding in th
